Rodas Justyne D, Sorkhou Maryam, George Tony P
Centre for Complex Interventions and Addictions Division, Centre for Addiction and Mental Health, Toronto, ON M6J 1H4, Canada.
Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada.
Brain Sci. 2022 Dec 23;13(1):36. doi: 10.3390/brainsci13010036.
Amongst individuals with a mental health disorder, a comorbid diagnosis of cannabis use disorder (CUD) is associated with numerous adverse consequences, including more severe symptom profiles, poorer treatment response, and reduced psychosocial functioning. Contingency management (CM), a method to specifically reinforce target behavior attainment (e.g., substance use abstinence), may provide an effective intervention in treating cannabis use in patients with a dual diagnosis of CUD and a mental health disorder. A systematic search examining the effects of CM on cannabis use, clinical, cognitive, and psychosocial outcomes in patients with a mental health disorder on PubMed, PsycINFO, and EMBASE databases up to November 2022 was performed. Six studies met inclusion criteria for our review. We found CM to be efficacious in producing cannabis use reductions and abstinence amongst individuals with a psychotic-spectrum or major depressive disorder. Additional longitudinal studies with larger sample sizes, other psychiatric populations, and longer follow-up periods are needed to evaluate the sustained effects of CM.
在患有精神健康障碍的个体中，大麻使用障碍（CUD）的共病诊断与许多不良后果相关，包括更严重的症状表现、较差的治疗反应以及心理社会功能下降。应急管理（CM）是一种专门强化目标行为达成（如戒除物质使用）的方法，可能为患有CUD和精神健康障碍双重诊断的患者治疗大麻使用提供有效干预。我们对截至2022年11月在PubMed、PsycINFO和EMBASE数据库中检索到的关于CM对患有精神健康障碍患者的大麻使用、临床、认知和心理社会结局影响的研究进行了系统检索。六项研究符合我们综述的纳入标准。我们发现CM在使患有精神病性谱系障碍或重度抑郁症的个体减少大麻使用和实现戒除方面是有效的。需要更多样本量更大、涉及其他精神疾病人群且随访期更长的纵向研究来评估CM的持续效果。
